Linking (Pyr)


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 31 10 2018
revised: 19 12 2018
accepted: 28 12 2018
pubmed: 4 1 2019
medline: 18 12 2019
entrez: 4 1 2019
Statut: ppublish

Résumé

Apelin, the endogenous ligand for the APJ receptor, has generated interest due to its beneficial effects on the cardiovascular system. Synthesized as a 77 amino acid preproprotein, apelin is post-translationally cleaved to a series of shorter peptides. Though (Pyr)

Identifiants

pubmed: 30605634
pii: S0003-2697(18)31120-5
doi: 10.1016/j.ab.2018.12.022
pii:
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0
Peptides 0
apelin-13 peptide 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-50

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Joelle M Onorato (JM)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA. Electronic address: joelle.onorato@bms.com.

Carrie Xu (C)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Xue-Qing Chen (XQ)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Anne V Rose (AV)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Claudia Generaux (C)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Kimberley Lentz (K)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Petia Shipkova (P)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Susan Arthur (S)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

James K Hennan (JK)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Roy Haskell (R)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Michael C Myers (MC)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

R Michael Lawrence (RM)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Heather J Finlay (HJ)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Michael Basso (M)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Jeffrey Bostwick (J)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Gayani Fernando (G)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Ricardo Garcia (R)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Samuel Hellings (S)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Mei-Yin Hsu (MY)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Rongan Zhang (R)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Lei Zhao (L)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Peter Gargalovic (P)

Drug Discovery, Bristol-Myers Squibb Company, Princeton, NJ, 08543-5400, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH